US 20100273895A1
· Stinchcomb et al.
· 2010
[cited by applicant]
US 20110086113A1
· Velasco Diez et al.
· 2011
[cited by applicant]
US 20200253919A1
· Raz et al.
· 2020
[cited by applicant]
US 20200408740A1
· Ballan et al.
· 2020
[cited by applicant]
US 20210052512A1
· Guy et al.
· 2021
[cited by applicant]
US 20210068444A1
· Alarcon et al.
· 2021
[cited by applicant]
US 20210069608A1
· Galyuk
· 2021
[cited by applicant]
US 20210128521A1
· Palaio
· 2021
[cited by applicant]
US 20210145764A1
· Lephart
· 2021
[cited by applicant]
US 20220000774A1
· Dely
· 2022
[cited by applicant]
US 20220054429A1
· Nathan et al.
· 2022
[cited by applicant]
US 20220062224A1
· Gubler et al.
· 2022
[cited by applicant]
US 20220248619A1
· Kleidon
· 2022
[cited by applicant]
US 20220253919A1
· Denner
· 2022
[cited by applicant]
US 20230015268A1
· Altman et al.
· 2023
[cited by applicant]
US 20230355645A1
· Storch et al.
· 2023
[cited by applicant]
CN 108433880A
· 2018
[cited by applicant]
CN 110063953A
· 2019
[cited by applicant]
EP 3368024A1
· 2018
[cited by applicant]
EP 3449992A1
· 2019
[cited by applicant]
EP 3544598A1
· 2019
[cited by applicant]
EP 3915550A1
· 2021
[cited by applicant]
EP 3937914A1
· 2022
[cited by applicant]
GB 2516335A
· 2015
[cited by applicant]
RU 2745687C1
· 2021
[cited by applicant]
WO WO2013165251A1
· 2013
[cited by applicant]
WO WO2014057067A1
· 2014
[cited by applicant]
WO WO2016187679A1
· 2016
[cited by applicant]
WO WO2017072773A1
· 2017
[cited by applicant]
WO WO2018167038A1
· 2018
[cited by applicant]
WO WO2019003163A2
· 2019
[cited by applicant]
WO WO2019034113A1
· 2019
[cited by applicant]
WO WO2019106652A1
· 2019
[cited by applicant]
WO WO2019145552A1
· 2019
[cited by applicant]
WO WO2019195943A1
· 2019
[cited by applicant]
WO WO2019222459A1
· 2019
[cited by applicant]
WO WO2020036655A9
· 2020
[cited by applicant]
WO WO2020163775A1
· 2020
[cited by applicant]
WO WO2020165878A1
· 2020
[cited by applicant]
WO WO2020183455A1
· 2020
[cited by applicant]
WO WO2020194237A1
· 2020
[cited by applicant]
WO WO2020209902A1
· 2020
[cited by applicant]
WO WO2021011790A1
· 2021
[cited by applicant]
WO WO2021016718A1
· 2021
[cited by applicant]
WO WO2021028646A1
· 2021
[cited by applicant]
WO WO2021099792A1
· 2021
[cited by applicant]
WO WO2021130728A1
· 2021
[cited by applicant]
WO WO2021158251A1
· 2021
[cited by applicant]
WO WO2021235977A1
· 2021
[cited by applicant]
WO WO2021240510A1
· 2021
[cited by applicant]
WO WO2021245522A1
· 2021
[cited by applicant]
WO WO2022011393A1
· 2022
[cited by applicant]
WO WO2022013854A1
· 2022
[cited by applicant]
WO WO2022016160A1
· 2022
[cited by applicant]
WO WO2022018708A1
· 2022
[cited by applicant]
WO WO2022105952A1
· 2022
[cited by applicant]
WO WO2022118303A1
· 2022
[cited by applicant]
WO WO2022144878A1
· 2022
[cited by applicant]
WO WO2022165349A1
· 2022
[cited by applicant]
WO WO2022165439A1
· 2022
[cited by applicant]
WO WO2022201043A1
· 2022
[cited by applicant]
WO WO2022204422A1
· 2022
[cited by applicant]
WO WO2022215071A1
· 2022
[cited by applicant]
WO WO2022225658A1
· 2022
[cited by applicant]
WO WO2023287742A1
· 2023
[cited by applicant]
WO WO2023014818A2
· 2023
[cited by applicant]
WO WO2023062634A1
· 2023
[cited by applicant]
Tomko et al, Anti-cancer properties of cannflavin A and potential synergistic. effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer. Journal of Cannabis Research, (Jul. 22, 2022) vol. 4, No. 1, pp. 1-…
[cited by examiner]
International Search Report issued in International Application No. PCT/US2023/077706 dated Feb. 28, 2024.
[cited by applicant]
Armour, et al., “Self-Management Strategies Amongst Australian Women With Endometriosis: A National Online Survey”, BMC Complementary and Alternative Medicine, vol. 19, No. 1, art. 17, Jan. 15, 2019, 1-8.
[cited by applicant]
Escudero-Lara, et al., “Disease-Modifying Effects of Natural Δ
[cited by applicant]
Fonseca, et al., “Cannabinoid-Induced Cell Death in Endometrial Cancer Cells: Involvement of TRPV1 Receptors in Apoptosis”, Journal of Physiology and Biochemistry, vol. 74, No. 2, Feb. 13, 2018, 261-272.
[cited by applicant]
Fraguas-Sánchez, et al., “Enhancing Ovarian Cancer Conventional Chemotherapy Through the Combination With Cannabidiol Loaded Microparticles”, European Journal of Pharmaceutics and Biopharmaceutics, vol. 154, Jul. 17, 20…
[cited by applicant]
Go, et al., “Cannabidiol Enhances Cytotoxicity of Anti-Cancer Drugs in Human Head and Neck Squamous Cell Carcinoma”, Scientific Reports, vol. 10, No. 1, art. 20622, Nov. 26, 2020, 1-11.
[cited by applicant]
Griffiths, et al., “Cannabidiol Suppresses 3-Dimensional Ovarian Cancer Growth and May Enhance Potency of Classic and Epigenetic Therapies”, Gynecologic Oncology, vol. 162, suppl. 1, Abstracts for the 2021 Society of Gy…
[cited by applicant]
Hazekamp, et al., “Preparative Isolation of Cannabinoids from Cannabis sativa by Centrifugal Partition Chromatography”, Journal of Liquid Chromatography & Related Technologies, vol. 27, No. 15, 2004, 2421-2439.
[cited by applicant]
Jaidee, et al., “Kinetics of CBD, Δ
[cited by applicant]
Jin, et al., “Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots”, Frontiers in Plant Science, vol. 12, ar…
[cited by applicant]
Kenyon, et al., “Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-Grade Synthetic Cannabidiol”, Anticancer Research, vol. 38, No. 10, Oct. 1, 2018, 5831-5835.
[cited by applicant]
Lazarjani, et al., “Processing and Extraction Methods of Medicinal Cannabis: A Narrative Review”, Journal of Cannabis Research, vol. 3, art. 32, Jul. 19, 2021, 1-15.
[cited by applicant]
Marinelli, et al., “The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer”, International Journal of Molecular Sciences, vol. 21, No. 15, art. 5409, Jul. 29, 2020, 1-22.
[cited by applicant]
Marinotti, et al., “Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science”, Journal of Dietary Supplements, vol. 17, No. 5, Jun. 16, 2020, 517-526.
[cited by applicant]
Midatech Pharma US Inc., Soltamox® Product Label, Revised Apr. 2019.
[cited by applicant]
Ökten, et al., “Cannabidiol as a Potential Novel Treatment for Endometriosis by Its Anti-Inflammatory and Anti- Oxidative Effects in an Experimental Rat Model”, Human Reproduction, vol. 37, issue supp. 1, Jun. 30, 2022,…
[cited by applicant]
Olivas-Aguirre, et al., “Tamoxifen Sensitizes Acute Lymphoblastic Leukemia Cells to Cannabidiol by Targeting Cyclophilin-D and Altering Mitochondrial Ca
[cited by applicant]
Rais, et al., “Phytochemicals in the Treatment of Ovarian Cancer”, Frontiers in Bioscience-Elite, vol. 9, No. 1, Jan. 1, 2017, 67-75.
[cited by applicant]
Raskin, et al., “Can an Apple a Day Keep the Doctor Away?”, Current Pharmaceutical Design, vol. 10, No. 27, Feb. 2004, 3419-3429.
[cited by applicant]
Rush, et al., “Cannabidiol: Assessing Activity in Ovarian and Endometrial Carcinoma Cell Lines”, Abstracts for the 2021 Society of Gynecologic Oncology 52nd Annual Meeting on Women's Cancer, Featured Posters 188—Poster …
[cited by applicant]
Sumanasekera, et al., “Hemp Extract With Specific Anti-Cancer Properties Against Ovarian Cancer”, The FASEB Journal Special Issue: Experimental Biology 2021 Meeting Abstracts, vol. 35, No. S1, May 14, 2021, https://doi.…
[cited by applicant]
Tallarida, “Quantitative Methods for Assessing Drug Synergism”, Genes & Cancer, vol. 2, No. 11, Apr. 19, 2012, 1003-1008.
[cited by applicant]
Tomko, et al., “Anti-Cancer Properties of Cannflavin A and Potential Synergistic Effects With Gemcitabine, Cisplatin, and Cannabinoids in Bladder Cancer”, Journal of Cannabis Research, vol. 4, art. 41, Jul. 22, 2022, 1-…
[cited by applicant]
Van Weelden, et al., “Anti-Estrogen Treatment in Endometrial Cancer: A Systematic Review”, Frontiers in Oncology, vol. 9, art. 359, May 7, 2019, 1-12.
[cited by applicant]
Boretto, et al., “Patient-Derived Organoids From Endometrial Disease Capture Clinical Heterogeneity and Are Amenable to Drug Screening”, Nature Cell Biology, vol. 21, Aug. 1, 2019, 1041-1051.
[cited by applicant]
Fraguas-Sánchez, Ana I., et al., “PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment”, Pharmaceutics, vol. 12, No. 5, art. 439, May 9, 202…
[cited by applicant]